Type:
Educational Exhibit
Keywords:
Abdomen, CNS, Thorax, CT, MR, PET-CT, Complications, Toxicity
Authors:
S. LON COLVÉE, M. Guerrero Martin, �. Rueda De Eusebio, S. Gómez Peña, M. D. C. Polidura Arruga, N. Gomez Ruiz, P. Hernandez Mateo, I. Martin Lores
DOI:
10.26044/ecr2023/C-14856
Learning objectives
The use of immune mediated treatment of cancer is improving dramatically the patient’s outcome and comfort, but it also carries new toxicity profiles. While standard antineoplastic therapy is associated with immunosuppression and infections, these new therapies induce overwhelming inflammation and autoimmunity. The vast majority of these adverse events can be classified as mild or moderate, but severe and life-threatening complications requiring ICU admission can also occur.
A considerable part of adverse effects related to immunotherapy can be diagnosed by imaging methods. This situation makes the role of the radiologist key when it comes to optimizing treatment individually for each patient, taking into account the risks and benefits of the different therapies.
This review will focus on the radiological approach to the new challenge that is to make an accurate and early diagnosis of these complications.